You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CUE Sale Disclosure
Lin Shao-lee · SEC Form 4 · Filed Oct 14, 2026
Sale
Calculated transaction value
$275K
Lin Shao-lee Chief Executive Officer
CUE
Cue Biopharma
CUE
Transaction date
Oct 12, 2026
Public filing date
Oct 14, 2026
Filing lag
Filed 2 days later
CUE daily price context
Close on/before transaction
$24.61
Oct 12, 2026
First close after public filing
$18.67
Oct 15, 2026
Return after filing · so far
-0.05%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $27.5
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001725092-26-000019
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$305.49K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cue Biopharma, Inc. CUE | Sale | Oct 12, 2026 | $30.49K |
| Cue Biopharma, Inc. CUE Current | Sale | Oct 12, 2026 | $275K |